161 related articles for article (PubMed ID: 30723294)
1. Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study.
Kuhn E; Ragazzi M; Ciarrocchi A; Torricelli F; de Biase D; Zanetti E; Bisagni A; Corrado S; Uccella S; La Rosa S; Bongiovanni M; Losito S; Piana S
Mod Pathol; 2019 Jun; 32(6):787-798. PubMed ID: 30723294
[TBL] [Abstract][Full Text] [Related]
2. Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.
Ragazzi M; Torricelli F; Donati B; Ciarrocchi A; de Biase D; Tallini G; Zanetti E; Bisagni A; Kuhn E; Giordano D; Frasoldati A; Piana S
Virchows Arch; 2021 Feb; 478(2):265-281. PubMed ID: 32683537
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
Begum S; Rosenbaum E; Henrique R; Cohen Y; Sidransky D; Westra WH
Mod Pathol; 2004 Nov; 17(11):1359-63. PubMed ID: 15195111
[TBL] [Abstract][Full Text] [Related]
5. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
Bishop JA; Sharma R; Westra WH
Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
[TBL] [Abstract][Full Text] [Related]
6. A case of coexistent angiosarcoma and follicular carcinoma of the thyroid.
Kim NR; Ko YH; Sung CO
J Korean Med Sci; 2003 Dec; 18(6):908-13. PubMed ID: 14676455
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
[TBL] [Abstract][Full Text] [Related]
8. [Primary angiosarcoma of the thyroid. Presentation of a case (epithelioid type) and nosological problems].
Bisceglia M; Vairo M; Tardio G; Scaramuzzi G; Zingrillo M
Pathologica; 1995 Apr; 87(2):154-61. PubMed ID: 8532409
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Nikiforov YE
Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
[TBL] [Abstract][Full Text] [Related]
11. Angiomatoid carcinoma and 'angiosarcoma' of the thyroid gland. A spectrum of endothelial differentiation.
Mills SE; Gaffey MJ; Watts JC; Swanson PE; Wick MR; LiVolsi VA; Nappi O; Weiss LM
Am J Clin Pathol; 1994 Sep; 102(3):322-30. PubMed ID: 8085556
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of thyroid gland angiomatoid tumors.
Cutlan RT; Greer JE; Wong FS; Eltorky M
Exp Mol Pathol; 2000 Oct; 69(2):159-64. PubMed ID: 11001864
[TBL] [Abstract][Full Text] [Related]
13. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Chernock RD; El-Mofty SK; Becker N; Lewis JS
Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
Bae JS; Kim Y; Jeon S; Kim SH; Kim TJ; Lee S; Kim MH; Lim DJ; Lee YS; Jung CK
Diagn Pathol; 2016 Feb; 11():21. PubMed ID: 26857243
[TBL] [Abstract][Full Text] [Related]
15. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
[TBL] [Abstract][Full Text] [Related]
16. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
Lam KY; Lo CY; Chan KW; Wan KY
Ann Surg; 2000 Mar; 231(3):329-38. PubMed ID: 10714625
[TBL] [Abstract][Full Text] [Related]
17. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
18. Glandular patterns in a thyroid carcinoma with insular and anaplastic features: a case with possible implications for the classification of thyroid carcinomas.
Fadare O; Sinard JH
Ann Diagn Pathol; 2002 Dec; 6(6):389-98. PubMed ID: 12478492
[TBL] [Abstract][Full Text] [Related]
19. [Angiomatoid tumor of the thyroid gland: primitive angiosarcoma or variant of anaplastic carcinoma?].
Njim L; Moussa A; Hadhri R; Gassab I; Ben Yahia N; Mahmoudi H; Zakhama A
Ann Pathol; 2008 Jun; 28(3):221-4. PubMed ID: 18706366
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
Bonhomme B; Godbert Y; Perot G; Al Ghuzlan A; Bardet S; Belleannée G; Crinière L; Do Cao C; Fouilloux G; Guyetant S; Kelly A; Leboulleux S; Buffet C; Leteurtre E; Michels JJ; Tissier F; Toubert ME; Wassef M; Pinard C; Hostein I; Soubeyran I
Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
